RoboStrategy Inc (NASDAQ: BOT) CEO Andrew Kang argues that specialized robotics companies, exemplified by Intuitive Surgical Inc (NASDAQ: ISRG), may offer greater investment value than general-purpose humanoid projects like Tesla Inc (NASDAQ: TSLA) Optimus.

Kang contends that dominating a single major labor market is sufficient to build a company worth hundreds of billions or even $1 trillion. This perspective contrasts with the broader ambition of creating a general-purpose humanoid capable of handling diverse physical tasks.

Specialized dominance drives valuation

Kang expects robotics valuations to diverge significantly, mirroring trends in the AI sector. Companies that fail to meet growth expectations or technological benchmarks will likely struggle, while those achieving scaled commercial deployment in specific sectors could see valuations rise.

According to Kang, the winners will be those that either solve general physical intelligence or harden their AI and hardware systems to dominate specific physical labor sectors. He identifies welding, material handling, and commercial services as large pools of physical work where specialized robots can prove economic value faster than generalists.

Intuitive Surgical as the blueprint

Intuitive Surgical provides a public-market example of this specialized success. The company has built a dominant position in robotic-assisted surgery without developing a general-purpose machine. Its da Vinci systems are designed specifically to assist surgeons in performing minimally invasive procedures.

The financial scale of this niche focus is substantial. Intuitive Surgical reported $10.1 billion in revenue for 2025, marking a 21% increase from the prior year. The company ended 2025 with more than 11,100 da Vinci systems installed globally.

As of September 29, Intuitive Surgical held a market capitalization of roughly $145 billion. This valuation supports Kang’s argument that a robot does not need to replicate the full range of human movement to support a massive business; it needs to become indispensable in a large, repeatable workflow.

Tesla pursues broader ambition

Tesla is explicitly pursuing the general-purpose version of robotics. The company describes Optimus as a bipedal autonomous humanoid designed to perform unsafe, repetitive, or boring tasks. This ambition aims to open a much larger addressable market but presents a more demanding technological challenge involving perception, movement, dexterity, and physical interaction.

What the numbers show

The divergence between Intuitive Surgical’s performance and the theoretical potential of general-purpose robots highlights a key market dynamic. Intuitive Surgical achieved $10.1 billion in revenue and a $145 billion market cap by solving one specific problem: minimally invasive surgery. In contrast, Tesla’s Optimus targets a wide array of tasks, which requires solving complex general physical intelligence issues before widespread commercial viability is proven. Kang’s analysis suggests that investors should watch both paths, but the faster path to massive valuation may lie in narrow markets where robots can prove their economic value quickly.

Intuitive Surgical (NASDAQ: ISRG) has delivered an average annual return of 17.12% over the past 10 years. The surgical robotics company has outperformed the broader market by 3.55% on an annualized basis during this period.

As of the time of writing, Intuitive Surgical holds a market capitalization of $132.12 billion. The stock price stood at $368.75.

Investment Growth Analysis

An investor who purchased $1,000 worth of ISRG shares 10 years ago would see that position grow to $4,935.75 today. This calculation is based on the current share price of $368.75.

What the Numbers Show

The data illustrates the impact of compounded returns on long-term capital growth. The divergence between the initial investment ($1,000) and the current value ($4,935.75) highlights how consistent annualized performance accumulates over a decade, resulting in a nearly five-fold increase in nominal value.

This article was generated by Benzinga's automated content engine and reviewed by an editor.